Governments and regulatory authorities are supporting the development of advanced cell therapies through favorable policies and faster approval processes. This support encourages pharmaceutical companies to invest more in CAR-T research. Such initiatives are boosting the overall market growth. CAR-T Cell Therapy Market to Reach US$ 10.13 Billion by 2030 with 17.5% CAGR The global CAR-T Cell...